Assyro AI

Orange Book product · Brand (NDA)

ACUVAIL

KETOROLAC TROMETHAMINE

Brand (NDA)NDA 022427RX ABBVIE

At a glance

Jul 22, 2009

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 22, 2009

    17 yr 2 mo ago

  2. Today

  3. Patent 8512717 expires

    Listed drug product patent expiration.

    Mar 07, 2028

    in 1 yr 9 mo

  4. Patent 9192571 expires

    Listed drug product patent expiration.

    Mar 07, 2028

    in 1 yr 9 mo

  5. Patent 7842714 expires

    Listed drug substance patent expiration.

    Aug 15, 2029

    in 3 yr 2 mo

Pharmaceutical detail

Active ingredient

KETOROLAC TROMETHAMINE

Strength

0.45%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 022427

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8512717Mar 07, 2028in 1 yr 9 mo
Product
9192571Mar 07, 2028in 1 yr 9 mo
Product
7842714Aug 15, 2029in 3 yr 2 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.